Innorna

Series-B
innorna.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-B
Last Announced Apr 1, 2022
Investors Undisclosed
Decision Makers 3 Available

About Innorna

Innorna is a clinical-stage biotechnology company engineering mRNA-based medicines to treat chronic diseases, power in vivo immunotherapies, and prevent infectious diseases — improving lives worldwide.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 9, 2026

Web & Domain Identity

Official Website innorna.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Innorna.

Funding History

1 Round
Series-B equity · Apr 1, 2022

Founders & Leadership

2

Cindy Zhang

Co-founder | Deputy General Manager

Work email & phone locked Unlock →

Linxian Li

Co-founder | Chairman | CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts